The authors of this study conclude that LL-37 may represent an important component of the human body’s innate defense against RSV infection, and prophylactic modulation of LL-37 expression, and/or the use of synthetic analogs after infection, may be a promising strategy for the development of compounds against RSV. Here, CAMP is linked to infection.